ReviewTherapeutics and clinical risk management2023

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis.

Joy Q Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.